These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 303817)
41. [Treatment of hemorrhages from esophageal varices with a vasopressin derivative]. Schröder P Med Welt; 1969 Feb; 8():436-7. PubMed ID: 5771344 [No Abstract] [Full Text] [Related]
44. Review of the medical management of acute variceal bleeding from the esophagus. Apesos J Med Ann Dist Columbia; 1973 Oct; 42(10):486-9. PubMed ID: 4594897 [No Abstract] [Full Text] [Related]
45. Efficacy of somatostatin and vasopressin in the control of acute variceal hemorrhage. Jenkins SA; Baxter JN; Corbett W; Devitt P; Ware J; Shields R Hepatology; 1985; 5(2):344-5. PubMed ID: 2858444 [No Abstract] [Full Text] [Related]
47. Severe hyponatremia and bradycardia associated with intravenous vasopressin therapy for variceal hemorrhage. Melo JA; Lee M; Munoz J; Levine SM J Clin Gastroenterol; 1995 Apr; 20(3):266-8. PubMed ID: 7797847 [No Abstract] [Full Text] [Related]
48. Local gangrene: a complication of peripheral Pitressin therapy for bleeding esophageal varices. Greenwald RA; Rheingold OJ; Chiprut RO; Rogers AI Gastroenterology; 1978 Apr; 74(4):744-6. PubMed ID: 305380 [TBL] [Abstract][Full Text] [Related]
49. [Treatment of acute hemorrhage from esophageal varices]. Egberts EH Z Gastroenterol Verh; 1983 Apr; 18():82-92. PubMed ID: 6192614 [No Abstract] [Full Text] [Related]
50. [Hemorrhage from esophageal varices. Treatment by posterior pituitary perfusion into the superior mesenteric artery]. Heully F; Grosdidier J; Gaucher P; Fays J; Boissel P; Jeanpierre R; Bigard MA Nouv Presse Med; 1972 Dec; 1(46):3129-31. PubMed ID: 4539839 [No Abstract] [Full Text] [Related]
51. [Somatostatin in the treatment of digestive hemorrhages secondary to rupture of esophageal varices]. Coraggio F; Spina M; Scarpato P; Ferrentino R; Lombardi S; Bellini M; Donisi M Clin Ter; 1984 Sep; 110(6):529-32. PubMed ID: 6149838 [No Abstract] [Full Text] [Related]
52. Addition of isoproterenol to reduce risk of vasopressin therapy. Skivolocki WP; Pace WG; Thomford NR Surg Forum; 1972; 23(0):336-7. PubMed ID: 4546172 [No Abstract] [Full Text] [Related]
53. Cutaneous reaction to vasopressin. Lemlich G; Di Grandi S; Szaniawski WK Cutis; 1996 May; 57(5):330-2. PubMed ID: 8726714 [TBL] [Abstract][Full Text] [Related]
54. Emergency management of acute profuse hemorrhage from esophageal varices. Zajac S; Walaszewski J; Szczerbań J; Nielubowicz J Pol Med J; 1972; 11(4):957-61. PubMed ID: 4538693 [No Abstract] [Full Text] [Related]
56. [Drug therapy and prevention of acute upper gastrointestinal hemorrhage]. Londong W Z Gastroenterol; 1983 Jun; 21(6):282-9. PubMed ID: 6137116 [TBL] [Abstract][Full Text] [Related]
57. Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study. Bonkovsky HL; Bonkovsky ML; Anderson PB; Rothstein RI; Erkkinen JF Am J Gastroenterol; 1989 Jun; 84(6):681-3. PubMed ID: 2658555 [No Abstract] [Full Text] [Related]
58. Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Conn HO; Ramsby GR; Storer EH; Mutchnick MG; Joshi PH; Phillips MM; Cohen GA; Fields GN; Petroski D Gastroenterology; 1975 Feb; 68(2):211-21. PubMed ID: 803910 [TBL] [Abstract][Full Text] [Related]